Serum Institute Capacity and Reach

Table: Serum Institute Capacity and Reach for Serum Institute of India. 4 rows across Metric, Company-stated value, Notes.
MetricCompany-stated valueNotes
Annual dose capacityAbout 4 billion dosesHadapsar and Manjari, Pune
Countries reached170+Including US, UK, and Europe
COVID-19 doses deliveredMore than 2 billionHistorical COVID volume, not a 2026 franchise
Founded1966, Pune (Cyrus Poonawalla)Company history

Serum Institute Company Milestones

Table: Serum Institute Company Milestones for Serum Institute of India. 6 rows across Date, Event, Source class.
DateEventSource class
1966Cyrus Poonawalla founds Serum Institute in PuneCompany history
2012-06Acquires Bilthoven Biologicals (IPV technology) from the Dutch governmentCompany history
2020-2023More than 2 billion COVID-19 doses deliveredCompany PR boilerplate
2025-06First company to submit a WHO vaccine PQ dossier in eCTD formatCompany PR, 10 Jun 2025
2026-03Bavarian Nordic chikungunya tech-transferCompany / Bavarian
2026-07Gates MRI M72 TB manufacturing agreement; Bundibugyo ebolavirus trial startCompany news

Serum Institute 2026 Partnerships

Table: Serum Institute 2026 Partnerships for Serum Institute of India. 3 rows across Date, Partner / program, What it is.
DatePartner / programWhat it is
2026-03Bavarian Nordic / VimkunyaChikungunya tech-transfer for LMIC supply. Volume path is SII, not branded travel ASP.
2026-07-16Gates Medical Research Institute / M72/AS01ETB vaccine-candidate manufacturing agreement, pending Phase 3
2026-07-24Oxford Vaccine Group / Bundibugyo ebolavirusFirst volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial

Serum Institute Named Vaccines

Table: Serum Institute Named Vaccines for Serum Institute of India. 6 rows across Product, Indication, Why it is on this card.
ProductIndicationWhy it is on this card
PneumosilPneumococcal conjugate (PCV)Company: world's most affordable PCV
CervavacQuadrivalent HPVFirst indigenous qHPV vaccine in India; Gavi HPV volume path
R21/Matrix-MMalaria in childrenSecond malaria vaccine authorized in endemic regions
MenFiveMeningococcal ACYWX conjugateFirst pentavalent ACYWX, WHO-prequalified for pediatrics
HEXASIILHexavalent wP-HepB-IPV-HibOn the WHO inspection product list
COVID-19 vaccines>2 billion doses deliveredHistorical volume, not a 2026 US seasonal story
Serum Institute of India in Vaccines cover

Serum Institute of India in Vaccines

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites
Serum Institute of India - KPIs | Sterling